BodyTel Scientific, Inc. Enters into Distribution Agreement with Diabetes Supplies Ltd. to Market GlucoTel in New Zealand
Published: Jun 24, 2008
JACKSONVILLE, Fla., June 24, 2008 (PRIME NEWSWIRE) -- BodyTel Scientific Inc. (OTCBB:BDYT), a developer of wireless telemedical devices, announces today that it has, through its wholly owned subsidiary BodyTel Europe GmbH, entered into an exclusive distribution agreement with Diabetes Supplies Ltd. (DSL), a well known distributor of medical supplies in New Zealand. Beginning in the third quarter of 2008, BodyTel's new partner, Diabetes Supplies, intends to begin offering BodyTel's blood glucose monitoring and diabetes management system, GlucoTel(tm), in New Zealand (the "Territory"). Pursuant to the terms of the distribution agreement, BodyTel granted DSL the right to exclusively market the GlucoTel in the Territory for a term of one year. Diabetes Supplies Ltd. is also responsible for all distribution, compliance and marketing costs relating to the sale of the products in the Territory.